Firms Slam Fresh Price Cut Threats

To read the full article, please choose one of the following options:

Smaller German drugmakers have opposed any further government moves to cut medicines costs, following deep reductions in generic drug prices in recent months. Germany's mid-sized pharmaceutical companies have witnessed a frenzy of M&A activity in recent weeks, at a time when the so-called Economic Optimization of Pharmaceutical Care Act (AVWG) is introducing harsh cost cuts..